Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
5.47
+0.40 (7.89%)
At close: Dec 5, 2025, 4:00 PM EST
5.39
-0.08 (-1.46%)
After-hours: Dec 5, 2025, 7:58 PM EST
Alvotech Market Cap
Alvotech has a market cap or net worth of $1.71 billion as of December 5, 2025. Its market cap has decreased by -54.59% in one year.
Market Cap
1.71B
Enterprise Value
2.95B
1-Year Change
-54.59%
Ranking
Category
Stock Price
$5.47
Market Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $1.71B, an increase of 461.96%. That is a compound annual growth rate of 40.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.71B | -57.09% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | 327.81M | 7.59% |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |